XML 24 R6.htm IDEA: XBRL DOCUMENT v3.20.2
Condensed Consolidated Statements of Stockholders' Equity (Unaudited) - USD ($)
$ in Thousands
Total
Common Stock
Additional Paid-In Capital
Accumulated Other Comprehensive Income (Loss)
Accumulated Deficit
Balance at Dec. 31, 2018 $ 119,945 $ 12 $ 323,279 $ (4) $ (203,342)
Balance (in shares) at Dec. 31, 2018   11,954,528      
Stock-based compensation expense 829   829    
Issuance of common stock from stock grants and option exercises 106   106    
Issuance of common stock from stock grants and option exercises, shares   19,576      
Unrealized (loss) gain on available-for-sale debt securities 17     17  
Net loss (15,082)       (15,082)
Balance at Mar. 31, 2019 105,815 $ 12 324,214 13 (218,424)
Balance (in shares) at Mar. 31, 2019   11,974,104      
Balance at Dec. 31, 2018 119,945 $ 12 323,279 (4) (203,342)
Balance (in shares) at Dec. 31, 2018   11,954,528      
Unrealized (loss) gain on available-for-sale debt securities 35        
Net loss (41,568)        
Balance at Sep. 30, 2019 81,272 $ 12 326,139 31 (244,910)
Balance (in shares) at Sep. 30, 2019   12,029,992      
Balance at Mar. 31, 2019 105,815 $ 12 324,214 13 (218,424)
Balance (in shares) at Mar. 31, 2019   11,974,104      
Stock-based compensation expense 903   903    
Stock-based compensation expense   5,999      
Issuance of common stock from stock grants and option exercises 129   129    
Issuance of common stock from stock grants and option exercises, shares   28,425      
Unrealized (loss) gain on available-for-sale debt securities 44     44  
Net loss (13,780)       (13,780)
Balance at Jun. 30, 2019 93,111 $ 12 325,246 57 (232,204)
Balance (in shares) at Jun. 30, 2019   12,008,528      
Stock-based compensation expense 801   801    
Stock-based compensation expense   7,393      
Issuance of common stock from stock grants and option exercises 92   92    
Issuance of common stock from stock grants and option exercises, shares   14,071      
Unrealized (loss) gain on available-for-sale debt securities (26)     (26)  
Net loss (12,706)       (12,706)
Balance at Sep. 30, 2019 81,272 $ 12 326,139 31 (244,910)
Balance (in shares) at Sep. 30, 2019   12,029,992      
Balance at Dec. 31, 2019 68,336 $ 12 326,810 34 (258,520)
Balance (in shares) at Dec. 31, 2019   12,040,835      
Stock-based compensation expense 805   805    
Stock-based compensation expense   7,817      
Issuance of common stock from stock grants and option exercises 339   339    
Issuance of common stock from stock grants and option exercises, shares   62,969      
Issuance of common stock for public offering, net of issuance costs of $2,514 and $ [ ] 31,986 $ 5 31,981    
Issuance of common stock for public offering, net of issuance costs of $2,514, shares   5,307,692      
Unrealized (loss) gain on available-for-sale debt securities 106     106  
Net loss (4,053)       (4,053)
Balance at Mar. 31, 2020 97,519 $ 17 359,935 140 (262,573)
Balance (in shares) at Mar. 31, 2020   17,419,313      
Balance at Dec. 31, 2019 68,336 $ 12 326,810 34 (258,520)
Balance (in shares) at Dec. 31, 2019   12,040,835      
Unrealized (loss) gain on available-for-sale debt securities (26)        
Net loss (37,334)        
Balance at Sep. 30, 2020 94,059 $ 22 389,883 8 (295,854)
Balance (in shares) at Sep. 30, 2020   22,082,924      
Balance at Mar. 31, 2020 97,519 $ 17 359,935 140 (262,573)
Balance (in shares) at Mar. 31, 2020   17,419,313      
Stock-based compensation expense 834   834    
Stock-based compensation expense   16,048      
Issuance of common stock for public offering, net of issuance costs of $2,514 and $ [ ] 27,955 $ 5 27,950    
Issuance of common stock for public offering, net of issuance costs of $2,514, shares   4,615,384      
Unrealized (loss) gain on available-for-sale debt securities (99)     (99)  
Net loss (17,248)       (17,248)
Balance at Jun. 30, 2020 108,961 $ 22 388,719 41 (279,821)
Balance (in shares) at Jun. 30, 2020   22,050,745      
Stock-based compensation expense 1,068   1,068    
Stock-based compensation expense   12,295      
Issuance of common stock from stock grants and option exercises 96   96    
Issuance of common stock from stock grants and option exercises, shares   19,884      
Unrealized (loss) gain on available-for-sale debt securities (33)     (33)  
Net loss (16,033)       (16,033)
Balance at Sep. 30, 2020 $ 94,059 $ 22 $ 389,883 $ 8 $ (295,854)
Balance (in shares) at Sep. 30, 2020   22,082,924